Gallium Ga-68 Psma-11 Injection, Solution
Product Images NDC 76394-2642

2 FDA label images from Ucla Biomedical Cyclotron · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Gallium Ga-68 Psma-11 (NDC 76394-2642). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ucla Biomedical Cyclotron, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Psma 11 01)

Chemical Structure (Psma 11 01)
Chemical structure of Gallium Ga-68 PSMA-11 (GALLIUM GA-68 GOZETOTIDE), showing the molecular arrangement including the gallium atom complexed with the ligand structure.*
FDA Label Image

Principal Display Panel (12 mL Vial Label)

Principal Display Panel (12 mL Vial Label)
Label for Gallium Ga 68 Gozetotide Injection, a multiple-dose vial containing 18.5 MBq/mL to 185 MBq/mL (0.5 mCi/mL to 5 mCi/mL) radioactive solution for intravenous use. The label lists handling instructions, storage conditions (20° to 25°C), expiration (3 hours after end of synthesis), and safety precaution of radioactive material. Manufactured by UCLA Biomedical Cyclotron, Los Angeles, CA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.